跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IL-23P40
首页
药物
IL-23P40
IL-23P40
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
SAFE AND EFFECTIVE METHOD OF TREATING ULCERATIVE COLITIS WITH ANTI-IL12/IL23 ANTIBODY
EP 3883606 A4
申请人: JANSSEN BIOTECH INC
优先权: 2018
CN
EP
US
WO
8 件公开
EP 4045085 A4
申请人: JANSSEN BIOTECH INC
优先权: 2019
CN
EP
US
WO
7 件公开
Chromatography column qualification in manufacturing methods for producing anti-IL12/IL23 antibody compositions
US 11079361 B2
申请人: JANSSEN BIOTECH INC
优先权: 2018
CN
US
WO
7 件公开
ANTI-IL-23 SPECIFIC ANTIBODY GUSELKUMAB FOR USE IN TREATING PSORIASIS
EP 3541422 B1
申请人: JANSSEN BIOTECH INC
优先权: 2016
EP
US
WO
6 件公开
METHOD OF TREATING PSORIASIS IN PEDIATRIC SUBJECTS WITH ANTI-IL12/IL23 ANTIBODY
EP 3941934 A4
申请人: JANSSEN BIOTECH INC
优先权: 2019
CN
EP
US
WO
5 件公开
IL-23p40 specific immunoglobulin derived proteins
US 7252971 B2
申请人: CENTOCOR INC
优先权: 2005
US
4 件公开
IL-23p40 specific antibody
US 7247711 B2
申请人: CENTOCOR INC
优先权: 2003
CN
US
3 件公开
SAFE AND EFFECTIVE METHOD OF TREATING ULCERATIVE COLITIS WITH ANTI-IL-12/IL23 ANTIBODY
EP 4103606 A4
申请人: JANSSEN BIOTECH INC
优先权: 2020
CN
EP
2 件公开
Safe and effective method of treating lupus with anti-IL12/IL23 antibody
US 12091452 B2
申请人: JANSSEN BIOTECH INC
优先权: 2018
US
2 件公开
US 11578124 B2
申请人: JANSSEN BIOTECH INC
优先权: 2019
US
Anti-IL-12/23p40 Antibodies, Epitopes, Formulations, Compositions, Methods and Uses
US 2009181027 A1
申请人: DAL MONTE PAUL
优先权: 2008
US
MANUFACTURING METHODS FOR PRODUCING ANTI-IL12/IL23 ANTIBODY COMPOSITIONS
CN 113825765 A
申请人: JANSSEN BIOTECH INC
优先权: 2019
CN
第 1 / 2 页
上一页
下一页
药物
反馈